Epigral Share Price
Start SIP in Epigral
Start SIPEpigral Performance
Day Range
- Low 1,826
- High 1,885
52 Week Range
- Low 872
- High 2,026
- Open Price1,868
- Previous Close1,864
- Volume57779
Epigral Investment Rating
-
Master Rating:
-
Epigral Ltd has an operating revenue of Rs. 2,125.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of 15% is great, ROE of 15% is good. The company has a reasonable debt to equity of 39%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 46% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 651 | 525 | 472 | 478 | 455 | 562 |
| Operating Expenses Qtr Cr | 475 | 369 | 349 | 370 | 360 | 407 |
| Operating Profit Qtr Cr | 176 | 155 | 123 | 108 | 95 | 155 |
| Depreciation Qtr Cr | 33 | 30 | 31 | 32 | 31 | 30 |
| Interest Qtr Cr | 14 | 14 | 20 | 21 | 18 | 19 |
| Tax Qtr Cr | 45 | 36 | 25 | 18 | 16 | 33 |
| Net Profit Qtr Cr | 86 | 77 | 49 | 38 | 32 | 77 |
Epigral Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹1,862.54
- 50 Day
- ₹1,729.10
- 100 Day
- ₹1,560.17
- 200 Day
- ₹1,378.51
- 20 Day
- ₹1,899.91
- 50 Day
- ₹1,708.56
- 100 Day
- ₹1,503.47
- 200 Day
- ₹1,274.92
Epigral Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,876.23 |
| Second Resistance | 1,910.12 |
| Third Resistance | 1,935.33 |
| RSI | 50.72 |
| MFI | 54.25 |
| MACD Single Line | 65.02 |
| MACD | 43.82 |
| Support | |
|---|---|
| First Support | 1,817.13 |
| Second Support | 1,791.92 |
| Third Supoort | 1,758.03 |
Epigral Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 60,850 | 2,793,624 | 45.91 |
| Week | 72,634 | 3,343,343 | 46.03 |
| 1 Month | 151,158 | 5,665,391 | 37.48 |
| 6 Month | 150,152 | 5,596,153 | 37.27 |
Epigral Result Highlights
Epigral Synopsis
NSE-Chemicals-Specialty
Epigral Ltd is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 1929.19 Cr. and Equity Capital is Rs. 41.55 Cr. for the Year ended 31/03/2024. Epigral Ltd. is a Public Limited Listed company incorporated on 11/09/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2007PLC051717 and registration number is 051717.| Market Cap | 7,655 |
| Sales | 2,125 |
| Shares in Float | 1.16 |
| No of funds | 70 |
| Yield | 0.27 |
| Book Value | 6.1 |
| U/D Vol ratio | 2.3 |
| LTDebt / Equity | 39 |
| Alpha | 0.14 |
| Beta | 1 |
Epigral Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 71.58% | 71.49% | 71.38% | 71.38% |
| Mutual Funds | 0.05% | 0.02% | 0.05% | 0.04% |
| Foreign Portfolio Investors | 1.46% | 1.36% | 1.17% | 1.14% |
| Individual Investors | 19.82% | 20.16% | 21.19% | 21.05% |
| Others | 7.09% | 6.97% | 6.21% | 6.39% |
Epigral Management
| Name | Designation |
|---|---|
| Mr. Maulik Jayantibhai Patel | Chairman & Managing Director |
| Mr. Kaushal Ashish Soparkar | Executive Director |
| Mr. Ankit Natwarlal Patel | Non Exe.Non Ind.Director |
| Mr. Karana Rameshbhai Patel | Non Exe.Non Ind.Director |
| Mr. Darshan Anandbhai Patel | Non Exe.Non Ind.Director |
| Mr. Manubhai Patel | Independent Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. Kanubhai Shakarabhai Patel | Independent Director |
| Mr. Raju Swamy | Independent Director |
| Ms. Nirali Parikh | Independent Director |
Epigral Forecast
Price Estimates
Epigral Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-14 | To consider Fund Raising | |
| 2024-07-24 | Quarterly Results | |
| 2024-04-22 | Audited Results & Final Dividend | |
| 2024-01-24 | Quarterly Results | |
| 2023-11-06 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-02 | FINAL | Rs.5.00 per share(50%)Final Dividend |
| 2023-06-20 | FINAL | Rs.2.50 per share(25%)Final Dividend |
| 2023-02-01 | INTERIM | Rs.2.50 per share(25%)Interim Dividend |
Epigral FAQs
What is Share Price of Epigral ?
Epigral share price is ₹1,842 As on 08 September, 2024 | 17:58
What is the Market Cap of Epigral ?
The Market Cap of Epigral is ₹7655 Cr As on 08 September, 2024 | 17:58
What is the P/E ratio of Epigral ?
The P/E ratio of Epigral is 30.6 As on 08 September, 2024 | 17:58
What is the PB ratio of Epigral ?
The PB ratio of Epigral is 6.1 As on 08 September, 2024 | 17:58